trastuzumab,neratinib
roche,knight therapeutics,pierre fabre,puma
['summit', 'neratinib', 'puma', 'pbyi', 'biotec']
first out// $pbyi: puma biotechnology presents final results from the biliary tract cohort of the phase 2 summit &amp;#39;basket&amp;#39; trial of neratinib at the asco 2022 annual
News platform.
Real-time market news alerts.